U.S., Sept. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07174401) titled 'Rocklatan Retinal Perfusion OCT Study' on Sept. 12.
Brief Summary: The main purpose of this study is to learn more about how Rocklatan eye drops affects blood flow in the eye. The secondary purpose is to see if our study devices can detect changes in blood flow before and after instillation of Rocklatan.
Study Start Date: Oct., 2025
Study Type: INTERVENTIONAL
Condition:
Glaucoma
Intervention:
DRUG: Rocklatan eye drops will be instilled nightly in one eye diagnosed with glaucoma for up to 12 months.
The eye not selected as the study eye will be used for comparison so both eyes will be imaged with the study devices to assess b...